A majority of Anterior Cruciate Ligament (ACL) reconstruction patients develop a condition known as posttraumatic osteoarthritis (PTOA) within 15 years of surgery, which can be debilitating and limit activity. Researchers are now highlighting how a set of biomarkers on the day of surgery may explain why some individuals have worse PTOA than others after two years.